{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T07:01:27Z","timestamp":1787900487306,"version":"build-2784847793"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Extramural Research Grant scheme by Science and Engineering Research Board, Department of Science and Technology, Govt. of India","award":["SERB\/EMR\/2015\/001785"],"award-info":[{"award-number":["SERB\/EMR\/2015\/001785"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.brainresbull.2020.04.013","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T05:02:15Z","timestamp":1587963735000},"page":"56-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Agmatine ameliorates manifestation of depression-like behavior and hippocampal neuroinflammation in mouse model of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"160","author":[{"given":"Nandkishor","family":"Kotagale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupali","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhura","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajshree","family":"Fating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milind","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brijesh","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainresbull.2020.04.013_bib0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/fcp.12034","article-title":"Participation of central imidazoline binding sites in antinociceptive effect of ethanol and nicotine in rats","volume":"28","author":"Aglawe","year":"2014","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0010","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00213-018-5137-8","article-title":"Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer\u2019s disease","volume":"236","author":"Amani","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3233\/JAD-2012-112003","article-title":"Apathy and depression in mild Alzheimer\u2019s disease: a cross-sectional study using diagnostic criteria","volume":"31","author":"Benoit","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0020","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.neuroscience.2010.05.004","article-title":"Agmatine protects against \u03b2-amyloid25-35-induced memory impairments in the rat","volume":"169","author":"Bergin","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0025","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1038\/s41598-019-49078-0","article-title":"Safety and neurochemical profiles of acute and sub-chronic oral treatment with agmatine sulfate","volume":"9","author":"Bergin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2011.07.012","article-title":"Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders","volume":"62","author":"Bernstein","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejphar.2009.10.022","article-title":"Depression and Alzheimer\u2019s disease: neurobiological links and common pharmacological targets","volume":"626","author":"Caraci","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0040","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.phrs.2018.02.007","article-title":"Neurobiological links between depression and AD: the role of TGF-\u03b21 signaling as a new pharmacological target","volume":"130","author":"Caraci","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0045","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2018.06.032","article-title":"Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid \u03b2 (A\u03b21-40) administration in mice","volume":"353","author":"de Souza","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/jnsbm.JNSBM_239_17","article-title":"Neuroprotective effect of agmatine in mouse spinal cord injury model: modulation by imidazoline receptors","volume":"9","author":"Dixit","year":"2018","journal-title":"J. Nat. Sci. Biol. Med."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2013.01.039","article-title":"Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-\u03b2 (A\u03b21-40) administration in mice","volume":"244","author":"dos Santos","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/0960327118788139","article-title":"Neuroprotective effect of agmatine (decarboxylated l-arginine) against oxidative stress and neuroinflammation in rotenone model of Parkinson\u2019s disease","volume":"38","author":"El-Sayed","year":"2018","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2014.07.024","article-title":"Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice","volume":"58","author":"Freitas","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0070","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1007\/s12035-015-9182-6","article-title":"Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice","volume":"53","author":"Freitas","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pnpbp.2017.03.010","article-title":"Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid \u03b2 (1-42) in mice","volume":"77","author":"Garcez","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2016.07.004","article-title":"Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators","volume":"149","author":"Gawali","year":"2016","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bbr.2018.06.032","article-title":"Agmatine attenuates depressive-like behavior and hippocampal oxidative stress following amyloid \u03b2 (A\u03b21-40) administration in mice","volume":"353","author":"Guerra de Souza","year":"2018","journal-title":"Behav. Brain Res."},{"issue":"11","key":"10.1016\/j.brainresbull.2020.04.013_bib0090","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2165\/00023210-200721110-00002","article-title":"Agmatine","volume":"21","author":"Halaris","year":"2007","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.brainresbull.2020.04.013_bib0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11033-018-4501-4","article-title":"The neuroprotective effect of agmatine against amyloid \u03b2-induced apoptosis in primary cultured hippocampal cells involving ERK, Akt\/GSK-3\u03b2, and TNF-\u03b1","volume":"46","author":"Hooshmandi","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.neuropharm.2016.10.029","article-title":"Agmatine ameliorates type 2 diabetes induced-Alzheimer\u2019s disease-like alterations in high-fat diet-fed mice via reactivation of blunted insulin signalling","volume":"113","author":"Kang","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3233\/JAD-148003","article-title":"Neuropathology of depression in alzheimer\u2019s disease: current knowledge and the potential for new treatments","volume":"44","author":"Khundakar","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbr.2010.04.049","article-title":"Repeated agmatine treatment attenuates nicotine sensitization in mice: modulation by \u03b12-adrenoceptors","volume":"213","author":"Kotagale","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0115","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2015.02.033","article-title":"Chronic agmatine treatment prevents behavioral manifestations of nicotine withdrawal in mice","volume":"754","author":"Kotagale","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pbb.2018.03.002","article-title":"Agmatine inhibits nicotine withdrawal induced cognitive deficits in inhibitory avoidance task in rats: contribution of \u03b12-adrenoceptors","volume":"167","author":"Kotagale","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0125","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.neuro.2019.05.001","article-title":"Neuroprotective offerings by agmatine","volume":"73","author":"Kotagale","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.neuropharm.2014.01.011","article-title":"Montelukast targeting the cysteinyl leukotriene receptor 1 ameliorates Ab1-42-induced memory impairment and neuroinflammatory and apoptotic responses in mice","volume":"79","author":"Lai","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0135","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.trci.2017.07.001","article-title":"Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: new treatment paradigms","volume":"3","author":"Lanctot","year":"2017","journal-title":"Alzheimers Dement. (N Y)."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-4328(02)00326-1","article-title":"Agmatine induces anxiolysis in the elevated plus maze task in adult rats","volume":"141","author":"Lavinsky","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0145","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mp.2012.168","article-title":"Amyloid-\u03b2 oligomers link depressive-like behavior and cognitive deficits in mice","volume":"18","author":"Ledo","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0150","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1523\/JNEUROSCI.1269-16.2016","article-title":"Cross talk between brain innate immunity and serotonin signaling underlies depressive-like behavior induced by alzheimer\u2019s amyloid- oligomers in mice","volume":"36","author":"Ledo","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0155","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s11064-007-9385-y","article-title":"Inflammation, depression and dementia: are they connected?","volume":"32","author":"Leonard","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/syn.20828","article-title":"Spatial learning-induced increase in agmatine levels at hippocampal CA1 synapses","volume":"65","author":"Leitch","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0165","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.neurobiolaging.2014.03.013","article-title":"Altered arginine metabolism in Alzheimer\u2019s disease brains","volume":"35","author":"Liu","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0170","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.phrs.2017.11.018","article-title":"Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer\u2019s disease","volume":"129","author":"Maione","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0175","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.116","article-title":"Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression","volume":"6","author":"Meylan","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2014.03.041","article-title":"Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt\/GSK3\u03b2 signaling disruption","volume":"736","author":"Moosavi","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0185","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s12640-015-9540-1","article-title":"Effects of agmatine on depressive-like behavior induced by intracerebroventricular administration of 1-Methyl-4-phenylpyridinium (MPP(+))","volume":"28","author":"Moretti","year":"2015","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JAD-2009-1051","article-title":"Brain-derived neurotrophic factor levels in Alzheimer\u2019s disease","volume":"17","author":"O\u2019Bryant","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainresbull.2016.04.007","article-title":"Alzheimer\u2019s therapy targeting the \u03b2-secretase enzyme BACE1: benefits and potential limitations from the perspective of animal model studies","volume":"126","author":"Ohno","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0200","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.pnpbp.2017.08.017","article-title":"Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone","volume":"81","author":"Olescowicz","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0205","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-161247","article-title":"Efficacy of antidepressants for depression in Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"58","author":"Orgeta","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2010.03.052","article-title":"Altered emotionality leads to increased pain tolerance in amyloid \u03b2 (A\u03b21-40) peptide-treated mice","volume":"212","author":"Pamplona","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0215","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpsychires.2006.10.011","article-title":"Platelet imidazoline receptors as state marker of depressive symptomatology","volume":"42","author":"Piletz","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0225","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0014-2999(79)90507-7","article-title":"Forced swimming in rats: hypothermia, immobility and the effects of imipramine","volume":"57","author":"Porsolt","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0230","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/0024-3205(95)00226-V","article-title":"Agmatine, the bacterial amine, is widely distributed in mammalian tissues","volume":"56","author":"Raasch","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0235","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjp.0704153","article-title":"Biological significance of agmatine, an endogenous ligand at imidazoline binding sites","volume":"133","author":"Raasch","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0240","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","article-title":"Is agmatine a novel neurotransmitter in brain?","volume":"21","author":"Reis","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0245","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1124\/jpet.105.086173","article-title":"Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse","volume":"314","author":"Roberts","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0250","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pnpbp.2017.05.004","article-title":"Antidepressant drugs for beta amyloid-induced depression: a new standpoint?","volume":"78","author":"Schiavone","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0255","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nn1503","article-title":"Regulation of NMDA receptor trafficking by amyloid-beta","volume":"8","author":"Snyder","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jad.2018.04.034","article-title":"Investigation of possible risk factors for depression in Alzheimer\u2019s disease: a systematic review of the evidence","volume":"236","author":"Steck","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0265","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.neuropharm.2009.06.035","article-title":"Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine","volume":"57","author":"Taksande","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0270","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2010.03.058","article-title":"Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats","volume":"637","author":"Taksande","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0275","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.euroneuro.2013.12.002","article-title":"Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats","volume":"24","author":"Taksande","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0280","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biopha.2016.12.039","article-title":"Agmatine ameliorates adjuvant induced arthritis and inflammatory cachexia in rats","volume":"86","author":"Taksande","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0285","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/070674370705200407","article-title":"Efficacy and safety of antidepressants for treatment of depression in Alzheimer\u2019s disease: Aa metaanalysis","volume":"52","author":"Thompson","year":"2007","journal-title":"Can. J. Psychiatry."},{"key":"10.1016\/j.brainresbull.2020.04.013_bib0290","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuroscience.2012.03.052","article-title":"Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA\/NMDA receptor density ratio in female Wistar-Kyoto rats","volume":"213","author":"Tizabi","year":"2012","journal-title":"Neuroscience"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923019309748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923019309748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:39:35Z","timestamp":1759783175000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923019309748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":58,"alternative-id":["S0361923019309748"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2020.04.013","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agmatine ameliorates manifestation of depression-like behavior and hippocampal neuroinflammation in mouse model of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2020.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}